Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,7611,206,3.81 [2.48-5.85],1.066341723006909e-09
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,7623,207,2.65 [1.76-3.98],2.952737131050063e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,6567,172,0.70 [0.60-0.81],3.221058113594795e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,6573,174,0.42 [0.36-0.48],6.62496838725625e-35
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,7659,207,1.44 [1.24-1.69],3.975482077919954e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,7586,204,0.51 [0.43-0.60],8.128108310476567e-16
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,6553,176,0.76 [0.70-0.82],2.68091378098248e-12
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,7455,202,0.43 [0.34-0.54],2.4592684074071368e-12
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,7437,205,2.35 [1.66-3.34],1.656093249770596e-06
